Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trial

Sheriza Baksh, Anne Casper, Mindy S Christianson, Kate Devine, Kevin J Doody, Stephan Ehrhardt, Karl R Hansen, Ruth B Lathi, Fatmata Timbo, Rebecca Usadi, Wendy Vitek, David M Shade, James Segars, Valerie L Baker, NatPro Study Group, Lusine Aghajanova, Ruben Alvero, Mary Andrews, Diego Arevalo, Emily Barnard, Aracely Casillas, Morgan Copeland, La Tasha B Craig, Kathleen M Doody, Ashley Eskew, Alma Gonzalez, Gretchen Hoelscher, Arthur Jason Vaught, Lynda Kochman, Andie Lears, Gaya Murugappan, Anna C Nackley, Tasha Newsome, Natalie Quintana, Bhuchitra Singh, Anna Sokalska, Michelle Starkey-Scruggs, Robin L Thomas, Deveine Toney, Irene Trueheart, Kisha Turner, Rebecca Usadi, Sally Villalobos, Anjali Wignarajah, Virginia Winn, Christy Zones, Sheriza Baksh, Anne Casper, Mindy S Christianson, Kate Devine, Kevin J Doody, Stephan Ehrhardt, Karl R Hansen, Ruth B Lathi, Fatmata Timbo, Rebecca Usadi, Wendy Vitek, David M Shade, James Segars, Valerie L Baker, NatPro Study Group, Lusine Aghajanova, Ruben Alvero, Mary Andrews, Diego Arevalo, Emily Barnard, Aracely Casillas, Morgan Copeland, La Tasha B Craig, Kathleen M Doody, Ashley Eskew, Alma Gonzalez, Gretchen Hoelscher, Arthur Jason Vaught, Lynda Kochman, Andie Lears, Gaya Murugappan, Anna C Nackley, Tasha Newsome, Natalie Quintana, Bhuchitra Singh, Anna Sokalska, Michelle Starkey-Scruggs, Robin L Thomas, Deveine Toney, Irene Trueheart, Kisha Turner, Rebecca Usadi, Sally Villalobos, Anjali Wignarajah, Virginia Winn, Christy Zones

Abstract

Background: Randomized trials of assisted reproductive technology (ART) have been designed for outcomes of clinical pregnancy or live birth and have not been powered for obstetric outcomes such as preeclampsia, critical for maternal and fetal health. ART increasingly involves frozen embryo transfer (FET). Although there are advantages of FET, multiple studies have shown that risk of preeclampsia is increased with FET compared with fresh embryo transfer, and the reason for this difference is not clear. NatPro will compare the proportion of preeclampsia between two commonly used protocols for FET,modified natural and programmed cycle.

Methods: In this two-arm, parallel-group, multi-center randomized trial, NatPro will randomize 788 women to either modified natural or programmed FET and follow them for up to three FET cycles. Primary outcome will be the proportion of preeclampsia in women with a viable pregnancy assigned to a modified natural cycle FET (corpus luteum present) protocol compared to the proportion of preeclampsia in pregnant women assigned to a programmed FET (corpus luteum absent) protocol. Secondary outcomes will compare the proportion of live births and the proportion of preeclampsia with severe features between the protocols.

Conclusion: This study has a potential significant impact on millions of women who pursue ART to build their families. NatPro is designed to provide clinically relevant guidance to inform patients and clinicians regarding maternal risk with programmed and modified natural cycle FET protocols. This study will also provide accurate point estimates regarding the likelihood of live birth with programmed and modified natural cycle FET.

Trial registration: ClinicalTrials.gov NCT04551807 . Registered on September 16, 2020.

Keywords: Frozen-thawed embryo transfer; Modified natural cycle; Preeclampsia; Programmed cycle.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Overview of patient flow, study procedures, and outcomes

References

    1. Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Dyer S. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Fertil Steril. 2018;110(6):1067–1080. doi: 10.1016/j.fertnstert.2018.06.039.
    1. Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, Tian L, Hao C, Yang D, Zhou F, Shi J, Xu Y, Li J, Yan J, Qin Y, Zhao H, Zhang H, Legro RS. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523–533. doi: 10.1056/NEJMoa1513873.
    1. Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson GD. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril. 2014;101(1):128–133. doi: 10.1016/j.fertnstert.2013.09.025.
    1. Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018;24(1):35–58. doi: 10.1093/humupd/dmx031.
    1. Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR, Wennerholm UB, Gissler M, Skjærven R, Romundstad LB. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30(7):1724–1731. doi: 10.1093/humrep/dev090.
    1. Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update. 2019;25(1):2–14. doi: 10.1093/humupd/dmy033.
    1. Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod. 2012;27(5):1343–1350. doi: 10.1093/humrep/des036.
    1. Sha T, Yin X, Cheng W, Massey IY. Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis. Fertil Steril. 2018;109(2):330–342. doi: 10.1016/j.fertnstert.2017.10.019.
    1. Sites CK, Wilson D, Barsky M, Bernson D, Bernstein IM, Boulet S, Zhang Y. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108(5):784–790. doi: 10.1016/j.fertnstert.2017.08.035.
    1. Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev. 2017;3:CD011184. doi: 10.1002/14651858.CD011184.pub2.
    1. Ginström Ernstad E, Wennerholm UB, Khatibi A, Petzold M, Bergh C. Neonatal and maternal outcome after frozen embryo transfer: Increased risks in programmed cycles. Am J Obstet Gynecol. 2019;221(2):126.e1–126e18. doi: 10.1016/j.ajog.2019.03.010.
    1. Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. The Lancet. 2016;387(10022):999–1011. doi: 10.1016/S0140-6736(15)00070-7.
    1. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016;102:47–50. doi: 10.1016/j.earlhumdev.2016.09.007.
    1. Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130(2):366–373. doi: 10.1097/AOG.0000000000002114.
    1. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59. doi: 10.1053/j.semperi.2011.09.011.
    1. Jarvie JL, Metz TD, Davis MB, Ehrig JC, Kao DP. Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy. Heart. 2018;104(14):1187–1194. doi: 10.1136/heartjnl-2017-312299.
    1. Oglaend B, Forman MR, Romundstad PR, Nilsen ST, Vatten LJ. Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J Hypertens. 2009;27(10):2051–2054. doi: 10.1097/HJH.0b013e328330052a.
    1. Staley JR, Bradley J, Silverwood RJ, Howe LD, Tilling K, Lawlor DA, et al. Associations of blood pressure in pregnancy with offspring blood pressure trajectories during childhood and adolescence: findings from a prospective study. J Am Heart Assoc. 2015;4(5):e001422. doi: 10.1161/JAHA.114.001422.
    1. Vaught AJ, Kovell LC, Szymanski LM, Mayer SA, Seifert SM, Vaidya D, Murphy JD, Argani C, O’Kelly A, York S, Ouyang P, Mukherjee M, Zakaria S. Acute cardiac effects of severe pre-eclampsia. J Am Coll Cardiol. 2018;72(1):1–11. doi: 10.1016/j.jacc.2018.04.048.
    1. von Versen-Hoynck F, Narasimhan P, Selamet Tierney ES, Martinez N, Conrad KP, Baker VL, et al. Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertension. 2019;73(3):680–690. doi: 10.1161/HYPERTENSIONAHA.118.12046.
    1. von Versen-Hoynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis M, et al. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73(3):640–649. doi: 10.1161/HYPERTENSIONAHA.118.12043.
    1. Wang Z, Liu H, Song H, Li X, Jiang J, Sheng Y, et al. Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles. Front Med (Lausanne) 2020;7:104. doi: 10.3389/fmed.2020.00104.
    1. Makhijani R, Bartels C, Godiwala P, Bartolucci A, Nulsen J, Grow D, Benadiva C, Engmann L. Maternal and perinatal outcomes in programmed versus natural vitrified-warmed blastocyst transfer cycles. Obstetrical & Gynecological Survey. 2020;75(11):679–680. doi: 10.1097/01.ogx.0000722056.80965.26.
    1. Saito K, Kuwahara A, Ishikawa T, Morisaki N, Miyado M, Miyado K, Fukami M, Miyasaka N, Ishihara O, Irahara M, Saito H. Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus. Human Reproduction. 2019;34(8):1567–1575. doi: 10.1093/humrep/dez079.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Boivin J, Takefman J, Braverman A. The fertility quality of life (FertiQoL) tool: development and general psychometric properties. Hum Reprod. 2011;26(8):2084–2091. doi: 10.1093/humrep/der171.
    1. Casper RF, Yanushpolsky EH. Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril. 2016;105(4):867–872. doi: 10.1016/j.fertnstert.2016.01.006.
    1. Mackens S, Santos-Ribeiro S, van de Vijver A, Racca A, Van Landuyt L, Tournaye H, et al. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Hum Reprod. 2017;32(11):2234–2242. doi: 10.1093/humrep/dex285.
    1. Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial. Fertil Steril. 2018;109(2):266–275. doi: 10.1016/j.fertnstert.2017.11.004.
    1. El-Toukhy T, Coomarasamy A, Khairy M, Sunkara K, Seed P, Khalaf Y, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril. 2008;89(4):832–839. doi: 10.1016/j.fertnstert.2007.04.031.
    1. Liu KE, Hartman M, Hartman A, Luo ZC, Mahutte N. The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers. Hum Reprod. 2018;33(10):1883–1888. doi: 10.1093/humrep/dey281.
    1. American College of Obstetricians and Gynecologists Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics & Gynecology. 2013;122(5):1122–1131. doi: 10.1097/01.AOG.0000437382.03963.88.
    1. Office for Human Research Protection . Unanticipated problems involving risks & adverse events guidance. 2007.
    1. Schoolcraft WB. Importance of embryo transfer technique in maximizing assisted reproductive outcomes. Fertility and Sterility. 2016;105(4):855–860. doi: 10.1016/j.fertnstert.2016.02.022.
    1. Bailey KR. Generalizing the results of randomized clinical trials. Control Clin Trials. 1994;15(1):15–23. doi: 10.1016/0197-2456(94)90024-8.
    1. Floyd EG, von Versen-Höynck F, Liu J, Chi YY, Fleischmann RR, Baker VL. Collection of pregnancy outcome records following infertility-challenges and possible solutions. J Assist Reprod Genet. 2016;33(8):993–999. doi: 10.1007/s10815-016-0733-1.
    1. Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43(4):825–831. doi: 10.1161/01.HYP.0000120122.39231.88.
    1. Bergink V, Laursen TM, Johannsen BM, Kushner SA, Meltzer-Brody S, Munk-Olsen T. Pre-eclampsia and first-onset postpartum psychiatric episodes: a Danish population-based cohort study. Psychol Med. 2015;45(16):3481–3489. doi: 10.1017/S0033291715001385.

Source: PubMed

3
Iratkozz fel